Veracyte (VCYT) Debt to Equity: 2012-2025
Historic Debt to Equity for Veracyte (VCYT) over the last 12 years, with Sep 2025 value amounting to $0.01.
- Veracyte's Debt to Equity rose 71.70% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 71.70%. This contributed to the annual value of $0.01 for FY2024, which is 467.44% up from last year.
- Per Veracyte's latest filing, its Debt to Equity stood at $0.01 for Q3 2025, which was down 1.78% from $0.01 recorded in Q2 2025.
- In the past 5 years, Veracyte's Debt to Equity registered a high of $0.01 during Q4 2024, and its lowest value of $0.00 during Q3 2023.
- Its 3-year average for Debt to Equity is $0.01, with a median of $0.01 in 2024.
- Its Debt to Equity has fluctuated over the past 5 years, first crashed by 64.57% in 2022, then surged by 467.44% in 2024.
- Quarterly analysis of 5 years shows Veracyte's Debt to Equity stood at $0.00 in 2021, then skyrocketed by 130.43% to $0.01 in 2022, then slumped by 54.85% to $0.00 in 2023, then surged by 467.44% to $0.01 in 2024, then surged by 71.70% to $0.01 in 2025.
- Its last three reported values are $0.01 in Q3 2025, $0.01 for Q2 2025, and $0.01 during Q1 2025.